Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Back to the future

Back to the future Only Seretide/Advair ($8.4bn), Abilify ($8bn) and Crestor ($6.9bn) prevented a biologic clean sweep of the bestsellers. .

Lundbeck agrees $658m deal to buy Chelsea Therapeutics

Lundbeck agrees $658m deal to buy Chelsea Therapeutics such as antidepressant Brintellix (vortioxetine) and Abilify Maintena (aripiprazole) to build sales momentum.

Double win for J&J's schizophrenia franchise

Double win for J&J's schizophrenia franchise leg-up in the market over competitors such as Lilly's Zypadhera (olanzapine) and Lundbeck's Abilify Maintena (aripiprazole), which has just been introduced in Europe.

Abilify Maintena launches in Europe

Abilify Maintena launches in Europe Lundbeck said today that Abilify Maintena will be on the market in 10 countries by the end of year. ... As a result Lundbeck is highlighting Abilify Maintena's ability to protect schizophrenia patients who have already been stabilised with oral

Pharma's winners and losers in 2013

Pharma's winners and losers in 2013 The company also faced declines for antipsychotic Abilify (aripiprazole) and irbesartan-based Avapro/Avalide for high blood pressure and growth of BMS' oncology and autoimmune disorder products could do little to

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...